Projektdetails

BMWF651479
26.05.2010
19.04.2016
beendet
NEPHRON+
-
33.000,00
- keines -
nein

beteiligte Personen/Organisationen

RolleLfnrName
Auftraggeber1Bundesministerium für Wissenschaft und Forschung (bis 28.2.2014)
Auftraggeber2Bundesministerium für Wissenschaft, Forschung und Wirtschaft (bis 07.01.2018)
Auftragnehmer1Donau-Universität Krems

zugeordnete Wissenschaftszweige

Wissenschaftszweige
HUMANMEDIZIN
Klinische Medizin
Nephrologie

Abstract deutsch

siehe 651.479/0001-WF/V/2/2015

Abstract englisch

This document reports the results for the in vitro validation of the WAKD (wearable artificial kidney device) laboratory prototype which is under development within the Nephron+ project. The device is intended to be used for continuous home treatment and will offer the patients more mobility and flexibility. The detoxification of the patients’ blood is conducted by an electrooxidation unit which degrades urea and other nitrogen-containing toxins as well as an adsorbent unit which adsorbs unwanted oxidation products as well as other uremic toxins. In order to remove excessive fluid, an ultrafiltration unit with a waste bag is introduced into the device. The WAKD was characterized regarding its efficiency of the removal for uremic toxins as well as for biocompatibility and cell toxicity. The efficiency and biocompatibility experiments were carried out with freshly drawn human blood which was spiked with target substances such as urea, creatinin and phosphate. Biocompatibility tests were carried out by contacting human cells in with fluid which was previously treated with the WAKD and, therefore, came in contact both with the adsorbent unit as well as with the electrooxidation unit. The in vitro experiments show that uremic toxins can be reduced significantly by the WAKD. However, even when taking into account that the WAKD is intended to be used continuously or at least for several hours every day, the detoxification efficiency is currently not comparable to conventional chronic dialysis treatment (3 times per week for 4 hours, total Kt/V ≥ 3.6) and most probably not sufficient to keep the toxins at an acceptable level. Further improvements have to be introduced for the final system. For the biocompatibility tests, basic parameters such as protein adsorption, removal of clotting parameters and hemolysis rates were assessed. Furthermore, advanced methods such as testing for oxidative stress, MTT test, Live-Dead assay and FACS analysis were conducted in order to check the impact of the electrooxidation on cells. The overall biocompatibility was good. No negative impact from electro-oxidation on the tested cells could be found with the applied methods. However, hemolysis is still high compared to conventional roller pumps, especially when taking into account that the system is intended to be used